Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome (Q44642267)

4 December 2017

title

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome (English)

1 reference

cytomegalovirus retinitis

4 December 2017

0 references

1 reference

Gross JG

1

1 reference

4 December 2017

Bozzette SA

2

1 reference

4 December 2017

Mathews WC

3

1 reference

4 December 2017

Spector SA

4

1 reference

4 December 2017

Abramson IS

5

1 reference

4 December 2017

McCutchan JA

6

1 reference

4 December 2017

Mendez T

7

1 reference

4 December 2017

Munguia D

8

1 reference

4 December 2017

Freeman WR

9

1 reference

4 December 2017

publication date

1 May 1990

1 reference

4 December 2017

1 reference

4 December 2017

volume

97

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

681-686

1 reference

Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS)

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Acquired immune deficiency syndrome. Ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Acquired immunodeficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Cytomegalovirus retinitis and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Severe visual loss related to isolated peripapillary retinal and optic nerve head cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Bilateral Retinal Detachment Following Cytomegalovirus Retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Rhegmatogenous Retinal Detachment Complicating Cytomegalovirus Retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Treatment of cytomegalovirus retinopathy with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Cytomegalovirus Infection of the Retina

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Cytomegalic inclusion retinitis in an adult.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Acquisition of donor strains of cytomegalovirus by renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Body mass repletion during ganciclovir treatment of cytomegalovirus infections in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932552-6

7 January 2021

10.1016/S0161-6420(90)32552-6

Identifiers

DOI

1 reference

4 December 2017

1 reference